Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-arm open-label study of sunitinib in progressive unresectable pancreatic neuroendocrine tumors
jRCT1080223150Phase 4Completed
- Sponsor
- Pfizer
- Start
- Mar 2016
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of sunitinib in islet cell tumor, sponsored by Pfizer. Started Mar 2016; status: completed.
02
Drugs
sunitinib
03
Conditions
islet cell tumor
Beyond the preview
Go deeper on jRCT1080223150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223150.